ArticleScientific reports2026
Longevity and foraging performance of honey bees treated with an RNAi-based Varroa destructor biopesticide.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Dose-dependent efficacy of a novel dsRNA-based solution containing vadescana for Varroa destructor control.Pest management science · 2026Article
- Localization and Functional Analysis of theInsects · 2026Article
- Insight into the Prospects of RNA Interference for Honey Bee Pathogens and Parasite Control.Insects · 2026Review
- Norroa™ as a dsRNA biopesticide forFrontiers in insect science · 2026Review
- Screening, optimization and artificial recombination of dsRNA fragments for RNAi-mediated pest resistance inFrontiers in insect science · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
RNA interference (RNAi) technology is a novel approach for Varroa destructor mite control. In this study, we investigated the effects of vadescana, a new dsRNA-based treatment, on bee longevity and foraging behaviour. Vadescana treated hives were compared to hives treated with a conventional miticide strip treatment, amitraz, and to untreated hives. Field bee hives were equipped with a radiofrequency identification (RFID) system and newly-hatched bees were tagged with RFID chips, allowing automated tracking of forager movements in and out of the hives. We found individual lifespan to be different for all treatments, with untreated bees having the shortest average survival times. Bees from amitraz-treated hives had the longest lifespans, with bees from vadescana-treated hives intermediate. Foraging behaviour analysis showed that vadescana treatment increased foraging activity. Bees were also recorded to drift between neighbouring hives and rob hives even in distant apiaries. Throughout the trial, mite numbers were monitored with bottom board counts and remained lowest for the vadescana treatment group. Our results highlight how parasitism with Varroa destructor is damaging to bees, reducing their foraging performance and longevity. Vadescana treatment in contrast, increased longevity and foraging activity in treated bees.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.